Search results

Page results

• Judicial review outcome: puberty blocking treatment for children

  The High Court has today ruled in favour of a judicial review claim which means children and young people may not be able to consent to hormone-blocking treatment in cases of gender dysphoria.

• NHS patients to benefit from state-of-the-art diagnostic tests for Parkinson’s & Mitochondrial diseases, resulting from a UK-first partnership

  Next generation testing, artificial intelligence, advanced mass spectrometry and machine learning is about to be used for diagnostics in the U.K. thanks to a new partnership between UCLH and Guilford Street Laboratories (GSL).

• What is Post-COVID-19 Syndrome? (Post-COVID Service)

  This page explains what Post-COVID-19 Syndrome is.

• Secretary of State visits UCLH vaccination centre at Bidborough House

  The Secretary of State for Health and Social Care Sajid Javid visited the UCLH vaccination centre at UCL’s Bidborough House on Thursday 23 September to see the vital role UCLH and UCL are playing in getting the UK’s population vaccinated for COVID-19.

• Outpatients

  Information for outpatients visiting UCLH hospitals.

• UCLH welcomes new clinical nurse specialist appointed to support asbestos-related cancer patients

  Sonya Moudart has been appointed as a Mesothelioma UK Clinical Nurse Specialist at UCLH. In her new role, Sonya will provide care and support for mesothelioma (asbestos-related cancer) patients and in time, will be a beacon of expertise in all matters relating to mesothelioma for the North Central London Cancer Alliance area. 

• New patient information

  Information for new neuro-otology patients

• Heather MacGregor, public governor

  I became a volunteer with the Trust in early 2022, after I retired from a career in family law, initially practising as a barrister and later as a District Judge of the Central Family Court.

• Launch of National Education Course for Sickle Cell Disorder

  A groundbreaking e-learning course dedicated to improving care and understanding of Sickle Cell Disorder (SCD) has been officially launched, marking a significant milestone in the fight against health inequalities.

• Genomics England drives sickle cell research through the diverse data initiative

  We are excited to share news that Genomics England has launched an initiative that will directly benefit patients from underrepresented populations such as those living with sickle cell disorder.